Screener
Aurinia Pharmaceuticals AUPH Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccountsAndOtherReceivablesNetCurrent.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
FAQ
- What is Aurinia Pharmaceuticals's accounts receivable?
- Aurinia Pharmaceuticals (AUPH) reported accounts receivable of $41.14M in Q2 2026.
- How has Aurinia Pharmaceuticals's accounts receivable changed year-over-year?
- Aurinia Pharmaceuticals's accounts receivable increased by 2.6% year-over-year, from $40.09M to $41.14M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.
Ask your AI about Aurinia Pharmaceuticals's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude